Tag: Eyestem

News Biotechnology

India’s Biotech Renaissance: Dr. Jogin Desai Forecasts Breakthrough Therapies Every Two Years

eyestem eyecyte rpe

India is transitioning from a global manufacturing hub to a leader in deeptech innovation. In this featured interview, Dr. Jogin Desai, CEO of Eyestem, explores how a compressed therapy timeline, the ₹10,000 crore Biopharma SHAKTI programme, and a focus on “reversing” rather than just “slowing” diseases are positioning India to deliver life-changing medical solutions to the world at a fraction of the traditional cost.

Clinical Trials Healthcare & Pharmaceuticals News

India’s Eyestem Receives CDSCO Nod for Phase 2 Trials of Breakthrough Blindness Therapy

eyestem eyecyte rpe

India’s Eyestem Research advances to Phase 2 clinical trials for Eyecyte-RPE™ following stellar Phase 1 results that showed significant vision restoration. As a scalable “off-the-shelf” solution for dry AMD, this therapy represents a major leap in regenerative medicine and a potential global cure for Geographic Atrophy.